Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe coronavirus disease 2019 (COVID-19)

Authors

Pierre Francois Laterre, Université Catholique de Louvain
Bruno François, University Hospital of Limoges
Christine Collienne, Université Catholique de Louvain
Philippe Hantson, Université Catholique de Louvain
Robin Jeannet, University Hospital of Limoges
Kenneth E. Remy, Washington University School of Medicine in St Louis
Richard S. Hotchkiss, Washington University School of Medicine in St Louis

Journal

JAMA Network Open

Publication Date

7-1-2020

Volume

3

Issue

7

First Page

e2016485

Document Type

Open Access Publication

DOI

10.1001/jamanetworkopen.2020.16485

Rights and Permissions

Laterre PF, François B, Collienne C, et al. Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19). JAMA Netw Open. 2020;3(7):e2016485. doi:10.1001/jamanetworkopen.2020.16485. This is an open access article distributed under the terms of the CC-BY License. © 2020 Laterre PF et al. JAMA Network Open.

Recommended Citation

Laterre, Pierre Francois; François, Bruno; Collienne, Christine; Hantson, Philippe; Jeannet, Robin; Remy, Kenneth E.; and Hotchkiss, Richard S., "Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe coronavirus disease 2019 (COVID-19)." JAMA Network Open. 3, 7. e2016485 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9280